feed,title,long_url,short_url
Benzinga,I-Mab Shares Gain On Licensing Pact For Its Human Growth Hormone In China,https://benzinga.com/general/biotech/21/11/24007566/i-mab-shares-gain-on-licensing-pact-for-its-human-growth-hormone-in-china,https://j.mp/3F2aIxN
Benzinga,"NuVasive's Q3 Earnings Hit By COVID-19, Staff Shortage; Cuts FY21 Guidance",https://benzinga.com/news/earnings/21/11/24007490/nuvasives-q3-earnings-hit-by-covid-19-staff-shortage-cuts-fy21-guidance,https://j.mp/3qrdmt0
Benzinga,Terns' Potential NASH Candidate Shows Potent Liver Target Engagement,https://benzinga.com/general/biotech/21/11/24007283/terns-potential-nash-candidate-shows-potent-liver-target-engagement,https://j.mp/3qEawkH
Benzinga,10 Biggest Price Target Changes For Wednesday,https://benzinga.com/analyst-ratings/price-target/21/11/24008403/10-biggest-price-target-changes-for-wednesday,https://j.mp/3bW6fAb
